CORE
🇺🇦
make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Rosiglitazone improves myocardial glucose uptake in patients with type 2 diabetes and coronary artery disease. A 16-Week randomized, double-blind, placebo-controlled study
Authors
K.E. Juhani Airaksinen
Elizabeth Ball
+10 more
Ronald Borra
Risto Harkonen
Patricia Iozzo
Juhani Knuuti
Riikka Lautamaki
Matti Luotolahti
Pirjo Nuutila
Marko Seppanen
Murray Stewart
Jyri Toikka
Publication date
3 November 2005
Publisher
'Salvia Medical Sciences Ltd'
Abstract
Abstract is not available.
Similar works
Full text
Available Versions
Via Medica Journals
See this paper in CORE
Go to the repository landing page
Download from data provider
oai:czasopisma.viamedica.pl:ar...
Last time updated on 15/12/2019